Directors Disqualified After Fake £9.8 Million NHS Contract Used to Secure Investment
Two directors of a medical equipment supplier have been banned from acting as company directors after an investigation revealed investors were misled through a fabricated NHS contract worth £9.8 million.
Tanveer Khan has been disqualified for 13 years after falsely claiming his company had secured a major contract to supply intensive care unit beds to NHS Wales. His wife, Tasneem Khan, has been disqualified for 10 years for her role in the company’s conduct.
The company at the centre of the case, Matz Medical Limited, entered administration in October 2022, leaving creditors facing losses of more than £40 million.
Tanveer Khan, 55, presented himself as the driving force behind a successful medical equipment supplier that was supposedly fulfilling a large NHS order for ICU beds. The contract, said to be worth £9.8 million, did not exist.
Using the fabricated agreement, Khan persuaded lenders and investors that Matz Medical Limited was supplying hundreds of high value hospital beds to an NHS Shared Services facility in Pontypool, South Wales. In reality, the company had been suspended from all NHS Supply Chain frameworks since 2019.
Tasneem Khan, 51, who was also a director of the company, supported the business during this period and played a role in providing documentation used to secure funding.
Both directors, who live in Loughton, Essex, oversaw the company throughout its trading life. Following an investigation by the Insolvency Service, Tanveer Khan was disqualified as a company director for 13 years at a High Court hearing in Manchester on 12 February 2026.
Tasneem Khan received a 10 year disqualification at the same hearing after the court found she had allowed the company to present false documentation and had signed a personal guarantee relating to one of the loans.
Their disqualifications took effect on 5 March 2026 and prevent them from forming, managing or promoting companies without the permission of the court.
Matz Medical Limited was incorporated in November 2013, with Tanveer and Tasneem Khan acting as its only directors throughout the life of the company. The business initially held NHS Supply Chain framework agreements, which allowed it to supply medical equipment to NHS organisations. NHS Supply Chain is responsible for sourcing and distributing healthcare products to NHS bodies and other healthcare organisations across England and Wales. However, in December 2019 NHS Supply Chain suspended all trading with Matz Medical Limited after an audit uncovered serious concerns relating to stock management, storage and labelling. The issues were considered sufficiently serious that continuing to trade posed potential risks to patient safety.
Despite no longer being permitted to supply through NHS Supply Chain frameworks, the company continued to seek external funding.
In March 2022, the business obtained £500,000 in loan funding after providing documentation stating the money was required to support NHS bed orders. Two months later, an investor paid £1.68 million to the company to purchase ICU beds connected to the supposed NHS contract that Matz Medical Limited claimed to hold.
Investigations by the Insolvency Service later found that several documents provided to support these funding requests had been fabricated. These included the alleged £9.8 million NHS purchase order, delivery notes claiming that more than 1,000 ICU beds had already been delivered, emails purporting to be from NHS officials confirming receipt of the equipment, and altered bank payment records showing funds being sent to a manufacturer.
Both the lender and the investor confirmed that they received no return on their investments and stated they would not have provided funding had they known the NHS contract did not exist.
Tanveer Khan was declared bankrupt in March 2023. While bankruptcy restrictions typically end after 12 months, his discharge has been suspended indefinitely after he failed to cooperate with the Official Receiver, the court appointed official responsible for investigating bankruptcies.
Trustees in his bankruptcy are continuing efforts to recover assets, including his home, in order to return funds to creditors.
In addition, a separate claim brought by the joint administrators against Tanveer Khan, estimated at around £16.5 million, remains ongoing. The claim relates to alleged breaches of his duties as a company director and the losses caused to creditors.
The disqualification orders will remain in place until March 2039 for Tanveer Khan and March 2036 for Tasneem Khan.